Thursday, April 2, 2009

Teva Introduces First Generic Adderall XR Capsules in the United States

Apr 2, 2009 - Teva Pharmaceutical Industries Ltd. announced today that it has commenced commercial shipment of its generic version of Shire Pharmaceuticals' Adderall XR® (mixed salts of a single-entity amphetamine product) Capsules, 5mg, 10mg, 15mg, 20mg, 25mg and 30 mg. Teva's generic Adderall XR Capsules are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD).

The details can be read here.

No comments: